ESMO Congress 2025

ESMO Congress 2025: Shaping the Future of Oncology

The ESMO Congress is a global forum bringing together clinicians, researchers, patient advocates, journalists, and healthcare industry representatives from around the world. We are excited to be part of this collaborative event, where we can engage in thought-provoking discussions and connect with leading experts in the field.

Our experts, including Dr Valentina Zhuokrova-Harill (Chief Medical Officer) and Nicolas Bouchet (Senior VP, Sales and Business Development), will be in attendance to discuss our contributions to oncology. This is also a valuable opportunity for our colleagues to network with international experts and professionals dedicated to improving cancer patient outcomes. We look forward to connecting with you and exploring new ways to advance the field together.

Key highlights of our expertise include:

• 100% oncology-experienced team
• 15 years: average experience of our team members in clinical trial delivery
• 306 oncology trials, including solid tumours, hematologic malignancies, rare and orphan indications
• Experience across Phases I–IV, in both adult and pediatric populations
• Products include drugs, devices, and combinations via various administration routes such as oral, IV, intratumoral, intralesional, etc.
• Global trial locations across APAC, Europe, LATAM, and North America